Biotechnology Assets, S.A. (BME:BST)

Biotechnology Assets Revenue

In the year 2025, Biotechnology Assets had annual revenue of 3.43M EUR, down -4.88%. Biotechnology Assets had revenue of 2.24M in the half year ending December 31, 2025, a decrease of -1.29%.

• Revenue: 3.43M
• Revenue Growth: -4.88%
• P/S Ratio: 4.55
• Revenue / Employee: 131.99K
• Employees: 26
• Market Cap: 15.60M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.43M	-175.95K	-4.88%
Dec 31, 2024	3.61M	-300.83K	-7.70%
Dec 31, 2023	3.91M	950.58K	32.14%
Dec 31, 2022	2.96M	-324.07K	-9.87%
Dec 31, 2021	3.28M	390.31K	13.50%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 14, 2026

Data Sources Report a data error